{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:46:59Z","timestamp":1774860419515,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504899"],"award-info":[{"award-number":["82504899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005145","name":"Basic Research Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20250773"],"award-info":[{"award-number":["BK20250773"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00770-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:53:00Z","timestamp":1774857180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The novel retinoid WYC-209 sensitizes multiple myeloma to carfilzomib via epigenetically upregulating ZMYND8"],"prefix":"10.1186","volume":"15","author":[{"given":"Jiaxuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"1","key":"770_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, Terpos E, Moukalled N, Hungria VTM, et al. Multiple myeloma. Nat Rev Dis Primers. 2024;10(1):45. https:\/\/doi.org\/10.1038\/s41572-024-00529-7.","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"770_CR2","doi-asserted-by":"publisher","first-page":"e2409219","DOI":"10.1002\/advs.202409219","volume":"12","author":"J Xu","year":"2025","unstructured":"Xu J, Dong X, Peng Y, Yan J, Xu P, Li F, et al. ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways. Adv Sci (Weinh). 2025;12(20):e2409219. https:\/\/doi.org\/10.1002\/advs.202409219.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"770_CR3","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1074\/jbc.M115.679985","volume":"291","author":"S Adhikary","year":"2016","unstructured":"Adhikary S, Sanyal S, Basu M, Sengupta I, Sen S, Srivastava DK, et al. Selective Recognition of H3.1K36 Dimethylation\/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8. J Biol Chem. 2016;291(6):2664\u201381. https:\/\/doi.org\/10.1074\/jbc.M115.679985.","journal-title":"J Biol Chem"},{"issue":"4","key":"770_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1182\/blood-2003-07-2391","volume":"103","author":"CR Walkley","year":"2004","unstructured":"Walkley CR, Purton LE, Snelling HJ, Yuan YD, Nakajima H, Chambon P, et al. Identification of the molecular requirements for an RAR alpha-mediated cell cycle arrest during granulocytic differentiation. Blood. 2004;103(4):1286\u201395. https:\/\/doi.org\/10.1182\/blood-2003-07-2391.","journal-title":"Blood"},{"issue":"1","key":"770_CR5","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-018-03877-7","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Cao X, An Q, Zhang Y, Li K, Yao W, et al. Inhibition of cancer stem cell like cells by a synthetic retinoid. Nat Commun. 2018;9(1):1406. https:\/\/doi.org\/10.1038\/s41467-018-03877-7.","journal-title":"Nat Commun"},{"issue":"1","key":"770_CR6","doi-asserted-by":"publisher","first-page":"2299288","DOI":"10.1080\/15384047.2023.2299288","volume":"25","author":"Z Qian","year":"2024","unstructured":"Qian Z, Lin W, Cai X, Wu J, Ke K, Ye Z, et al. WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARalpha. Cancer Biol Ther. 2024;25(1):2299288. https:\/\/doi.org\/10.1080\/15384047.2023.2299288.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"770_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbagrm.2017.02.004","volume":"1860","author":"M Basu","year":"2017","unstructured":"Basu M, Khan MW, Chakrabarti P, Das C. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochim Biophys Acta Gene Regul Mech. 2017;1860(4):450\u20139. https:\/\/doi.org\/10.1016\/j.bbagrm.2017.02.004.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"770_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41419-017-0173-6","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, He Y, Liang Z, Wang Y, Chen F, Djekidel MN, et al. Alterations of specific chromatin conformation affect ATRA-induced leukemia cell differentiation. Cell Death Dis. 2018;9(2):200. https:\/\/doi.org\/10.1038\/s41419-017-0173-6.","journal-title":"Cell Death Dis"},{"key":"770_CR9","doi-asserted-by":"publisher","first-page":"113451","DOI":"10.1016\/j.ejmech.2021.113451","volume":"220","author":"C Liang","year":"2021","unstructured":"Liang C, Qiao G, Liu Y, Tian L, Hui N, Li J, et al. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. Eur J Med Chem. 2021;220:113451. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113451.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"770_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/10428190310001628158","volume":"45","author":"K Koskela","year":"2004","unstructured":"Koskela K, Pelliniemi TT, Pulkki K, Remes K. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I\/II trial. Leuk Lymphoma. 2004;45(4):749\u201354. https:\/\/doi.org\/10.1080\/10428190310001628158.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"770_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2012.03.056","volume":"420","author":"JL Gu","year":"2012","unstructured":"Gu JL, Li J, Zhou ZH, Liu JR, Huang BH, Zheng D, et al. Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma. Biochem Biophys Res Commun. 2012;420(3):644\u201350. https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.056.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"770_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood.2020009856","volume":"139","author":"Q Wang","year":"2022","unstructured":"Wang Q, Lin Z, Wang Z, Ye L, Xian M, Xiao L, et al. RARgamma activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 2022;139(1):59\u201372. https:\/\/doi.org\/10.1182\/blood.2020009856.","journal-title":"Blood"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00770-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00770-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00770-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:53:01Z","timestamp":1774857181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00770-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00770-8","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethical and Welfare Committee of Nanjing University (IACUC-2302005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}